These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23992801)

  • 1. Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Hiligsmann M; Cooper C; Arden N; Boers M; Branco JC; Luisa Brandi M; Bruyère O; Guillemin F; Hochberg MC; Hunter DJ; Kanis JA; Kvien TK; Laslop A; Pelletier JP; Pinto D; Reiter-Niesert S; Rizzoli R; Rovati LC; Severens JL; Silverman S; Tsouderos Y; Tugwell P; Reginster JY
    Semin Arthritis Rheum; 2013 Dec; 43(3):303-13. PubMed ID: 23992801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Hiligsmann M; Cooper C; Guillemin F; Hochberg MC; Tugwell P; Arden N; Berenbaum F; Boers M; Boonen A; Branco JC; Maria-Luisa B; Bruyère O; Gasparik A; Kanis JA; Kvien TK; Martel-Pelletier J; Pelletier JP; Pinedo-Villanueva R; Pinto D; Reiter-Niesert S; Rizzoli R; Rovati LC; Severens JL; Silverman S; Reginster JY
    Semin Arthritis Rheum; 2014 Dec; 44(3):271-82. PubMed ID: 25086470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Honvo G; Bannuru RR; Bruyère O; Rannou F; Herrero-Beaumont G; Uebelhart D; Cooper C; Arden N; Conaghan PG; Reginster JY; Thomas T; McAlindon T
    Drugs Aging; 2019 Apr; 36(Suppl 1):145-159. PubMed ID: 31073927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing obesity in the management of knee and hip osteoarthritis - weighing in from an economic perspective.
    Flego A; Dowsey MM; Choong PF; Moodie M
    BMC Musculoskelet Disord; 2016 May; 17():233. PubMed ID: 27229924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.
    Hiligsmann M; Reginster JY; Tosteson ANA; Bukata SV; Saag KG; Gold DT; Halbout P; Jiwa F; Lewiecki EM; Pinto D; Adachi JD; Al-Daghri N; Bruyère O; Chandran M; Cooper C; Harvey NC; Einhorn TA; Kanis JA; Kendler DL; Messina OD; Rizzoli R; Si L; Silverman S
    Osteoporos Int; 2019 Jan; 30(1):45-57. PubMed ID: 30382319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO).
    Biver E; Berenbaum F; Valdes AM; Araujo de Carvalho I; Bindels LB; Brandi ML; Calder PC; Castronovo V; Cavalier E; Cherubini A; Cooper C; Dennison E; Franceschi C; Fuggle N; Laslop A; Miossec P; Thomas T; Tuzun S; Veronese N; Vlaskovska M; Reginster JY; Rizzoli R
    Ageing Res Rev; 2019 Nov; 55():100946. PubMed ID: 31437484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Honvo G; Veronese N; Arden NK; Branco J; Curtis EM; Al-Daghri NM; Herrero-Beaumont G; Martel-Pelletier J; Pelletier JP; Rannou F; Rizzoli R; Roth R; Uebelhart D; Cooper C; Reginster JY
    Semin Arthritis Rheum; 2019 Dec; 49(3):337-350. PubMed ID: 31126594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Reginster JL; Arden NK; Haugen IK; Rannou F; Cavalier E; Bruyère O; Branco J; Chapurlat R; Collaud Basset S; Al-Daghri NM; Dennison EM; Herrero-Beaumont G; Laslop A; Leeb BF; Maggi S; Mkinsi O; Povzun AS; Prieto-Alhambra D; Thomas T; Uebelhart D; Veronese N; Cooper C
    Semin Arthritis Rheum; 2018 Aug; 48(1):1-8. PubMed ID: 29287769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home treatment for mental health problems: a systematic review.
    Burns T; Knapp M; Catty J; Healey A; Henderson J; Watt H; Wright C
    Health Technol Assess; 2001; 5(15):1-139. PubMed ID: 11532236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis.
    Andrews G; Simonella L; Lapsley H; Sanderson K; March L
    J Rheumatol; 2006 Apr; 33(4):671-80. PubMed ID: 16541479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
    Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
    Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    de Wit M; Cooper C; Tugwell P; Bere N; Kirwan J; Conaghan PG; Roberts C; Aujoulat I; Al-Daghri N; Araujo de Carvalho I; Barker M; Bedlington N; Brandi ML; Bruyère O; Burlet N; Halbout P; Hiligsmann M; Jiwa F; Kanis JA; Laslop A; Lawrence W; Pinto D; Prieto Yerro C; Rabenda V; Rizzoli R; Scholte-Voshaar M; Vlaskovska M; Reginster JY
    Aging Clin Exp Res; 2019 Jul; 31(7):905-915. PubMed ID: 30993659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we reduce disease burden from osteoarthritis?
    Segal L; Day SE; Chapman AB; Osborne RH
    Med J Aust; 2004 Mar; 180(S5):S11-7. PubMed ID: 14984357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluation.
    Xie F; Tanvejsilp P; Campbell K; Gaebel K
    Drugs Aging; 2013 May; 30(5):277-84. PubMed ID: 23420120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of the Evolution of Health-Economic Evaluation Models of Osteoarthritis.
    Zhao T; Ahmad H; de Graaff B; Xia Q; Winzenberg T; Aitken D; Palmer AJ
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1617-1627. PubMed ID: 32799431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
    Bereza BG; Machado M; Einarson TR
    Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and consequences of acupuncture as a treatment for chronic pain: a systematic review of economic evaluations conducted alongside randomised controlled trials.
    Ambrósio EM; Bloor K; MacPherson H
    Complement Ther Med; 2012 Oct; 20(5):364-74. PubMed ID: 22863652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF).
    Hiligsmann M; Cornelissen D; Vrijens B; Abrahamsen B; Al-Daghri N; Biver E; Brandi ML; Bruyère O; Burlet N; Cooper C; Cortet B; Dennison E; Diez-Perez A; Gasparik A; Grosso A; Hadji P; Halbout P; Kanis JA; Kaufman JM; Laslop A; Maggi S; Rizzoli R; Thomas T; Tuzun S; Vlaskovska M; Reginster JY
    Osteoporos Int; 2019 Nov; 30(11):2155-2165. PubMed ID: 31388696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Moon RJ; Reginster JY; Al-Daghri NM; Thiyagarajan JA; Beaudart C; Bruyère O; Burlet N; Chandran M; da Silva MC; Conaghan PG; Dere WH; Diez-Perez A; Hadji P; Halbout P; Hiligsmann M; Kanis JA; McCloskey EV; Ormarsdottir S; Prieto-Alhambra D; Radermecker RP; Rizzoli R; Al-Saleh Y; Silverman SL; Simon LS; Thomasius F; van Staa T; Laslop A; Cooper C; Harvey NC
    Osteoporos Int; 2023 Aug; 34(8):1283-1299. PubMed ID: 37351614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.